ZBH · Zimmer Biomet Holdings, Inc.
$92.82
+0.41% last session
End-of-day data · close of 2026-09-11
Market cap
$18B
Enterprise value
$25B
Trailing P/E
22.4
Forward P/E
10.2
Dividend yield
1.0%
Beta
0.47
Avg volume
2M
Employees
17K
Daily Change %
0.41%
5 Days Change
-3.53%
10 Days Change
-5.43%
30 Days Change
-2.69%
60 Days Change
3.58%
Month to Day Change
-4.82%
Year to Day Change
5.78%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — ZBH
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-08-10
Latest call per bank · past 12 months
RBC Capital
Outperform$110
+19.0% vs priceCitigroup
Neutral$93.00
+0.6% vs priceJP Morgan
Neutral$95.00
+2.8% vs priceWells Fargo
Equal-Weight$90.00
-2.6% vs priceBarclays
Underweight$94.00
+1.7% vs priceUBS
Sell$86.00
-7.0% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-10 | Canaccord Genuity | Maintains | Hold | $83.00 → $100 |
| 2026-08-07 | Truist Securities | Maintains | Hold | $92.00 → $106 |
| 2026-08-06 | RBC Capital | Maintains | Outperform | $101 → $110 |
| 2026-08-06 | Bernstein | Maintains | Market Perform | $91.00 → $93.00 |
| 2026-08-06 | Stifel | Maintains | Buy | $105 → $110 |
| 2026-07-09 | BMO Capital | Initiates | Outperform → Market Perform | $0.00 → $95.00 |
| 2026-07-06 | Evercore ISI Group | Maintains | Outperform | $120 → $110 |
| 2026-05-28 | Citigroup | Maintains | Neutral | $95.00 → $93.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-09-11
- RSI (14): RSI is 38 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 2.6% below the 50-day MA ($95.32).
- Price vs 200-day MA: Trading 1.9% above the 200-day MA ($91.13).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is negative (-1.17) — short-term momentum is fading.
- 52-week range: Price sits between the 52-week low ($79.37) and high ($103.17).
ZBH Price Chart
Loading chart for ZBH…
Fundamentals
About Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
More in Medical Devices
ABT
Abbott Laboratories
$179B -14.4% YTD
MDT
Medtronic plc.
$117B -2.7% YTD
SYK
Stryker Corporation
$104B -21.2% YTD
BSX
Boston Scientific Corporation
$62B -52.8% YTD
EW
Edwards Lifesciences Corporatio
$50B 1.1% YTD
DXCM
DexCom, Inc.
$32B 26.4% YTD
GEHC
GE HealthCare Technologies Inc.
$29B -20.4% YTD
PHG
Koninklijke Philips N.V. NY Reg
$24B -4.0% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.